Delivery Order SPE2DB22D3301-SPE2DB25FY8RB
Award Date 7/31/25
Potential Completion Date 8/21/25
Potential Value $28K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $100,573.20 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 unit vials, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product used in medical applications, and this order supports the federal...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of XEOMIN 100 UT vials valued at $9,498.58 under a firm fixed price contract type. The delivery order, which is expected to be completed by August 28, 2025, represents a non-competitive award with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product commonly used in medical and cosmetic...
- The Defense Logistics Agency awarded a $1,955.59 delivery order to AmerisourceBergen Drug Corp for XEOMIN 100 Unit Vials, with an ultimate completion date of July 16, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. XEOMIN is a botulinum toxin product used in medical and cosmetic applications, procured through the federal supply chain for military and healthcare system use. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,117.48 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-competitive set-aside and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $5,587.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of XEOMIN 200 Unit Vials, with performance to be completed by August 1, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product used in medical and therapeutic applications, and this delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,352.44 to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin product used for medical purposes. This firm fixed price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-competed award under the company's existing contract vehicle with the DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of XEOMIN 50 unit vials, with a ceiling value of $10,941.84 and a firm fixed price structure. This non-set-aside contract is scheduled for completion by September 30, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. XEOMIN is a botulinum toxin product used in medical and cosmetic applications, and this delivery...
- The Defense Logistics Agency awarded a $8,939.84 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin-based pharmaceutical used for therapeutic and cosmetic applications. This competitively awarded, firm fixed-price contract was issued on September 12, 2025, with an ultimate completion date of October 3, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of XEOMIN 100 Unit vials. This firm fixed-price delivery order, valued at $23,467.08, represents a non-competitive set-aside award and is scheduled for completion by August 7, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award is issued as a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XEOMIN 100 Unit Vials, valued at $5,587.40 under firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of August 28, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, specifically supporting military and veteran...